Wells Fargo
PLRX icon

Wells Fargo’s Pliant Therapeutics PLRX Stock Holding History

Wells Fargo’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57 Hold
50
– – ﹤0.01% 6710
2026
Q1 		$63 Hold
50
– – ﹤0.01% 6561
2025
Q4 		$61 Hold
50
– – ﹤0.01% 6487
2025
Q3 		$74 Sell
50
-2,279
-98% -$3.48K ﹤0.01% 6424
2025
Q2 		$2.7K Sell
2,329
-33,122
-93% -$46.8K ﹤0.01% 6174
2025
Q1 		$47.9K Sell
35,451
-50,429
-59% -$306K ﹤0.01% 5420
2024
Q4 		$1.13M Sell
85,880
-7,352
-8% -$100K ﹤0.01% 3619
2024
Q3 		$1.05M Buy
93,232
+13,006
+16% +$163K ﹤0.01% 3520
2024
Q2 		$862K Buy
80,226
+8,876
+12% +$114K ﹤0.01% 3581
2024
Q1 		$1.06M Buy
71,350
+2,180
+3% +$36K ﹤0.01% 3418
2023
Q4 		$1.25M Buy
69,170
+51,468
+291% +$783K ﹤0.01% 3276
2023
Q3 		$307K Sell
17,702
-6,934
-28% -$120K ﹤0.01% 4080
2023
Q2 		$446K Buy
24,636
+23,294
+1,736% +$551K ﹤0.01% 4033
2023
Q1 		$35.7K Buy
1,342
+1,113
+486% +$31.7K ﹤0.01% 5346
2022
Q4 		$4.43K Sell
229
-204
-47% -$4.26K ﹤0.01% 5811
2022
Q3 		$9K Buy
433
+75
+21% +$1.44K ﹤0.01% 5732
2022
Q2 		$3K Sell
358
-1,857
-84% -$11.9K ﹤0.01% 6208
2022
Q1 		$15K Sell
2,215
-8,503
-79% -$86.8K ﹤0.01% 6126
2021
Q4 		$145K Buy
10,718
+10,508
+5,004% +$167K ﹤0.01% 5444
2021
Q3 		$4K Sell
210
-41,536
-99% -$882K ﹤0.01% 6448
2021
Q2 		$1.22M Buy
41,746
+10,694
+34% +$333K ﹤0.01% 4077
2021
Q1 		$1.22M Buy
31,052
+15,350
+98% +$498K ﹤0.01% 4106
2020
Q4 		$357K Buy
15,702
+7,660
+95% +$192K ﹤0.01% 4766
2020
Q3 		$182K Buy
+8,042
New +$201K ﹤0.01% 5007

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Wells Fargo's PLRX Position: Q2 2026 in Review

Wells Fargo held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 50 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #6710.

Wells Fargo first reported a position in PLRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.25M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Wells Fargo held 50 shares of Pliant Therapeutics worth $57 as of Q2 2026.
  • Wells Fargo left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6710 holding.
  • Wells Fargo first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Wells Fargo's Pliant Therapeutics position peaked at $1.25M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.